⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →

Gujarat Kidney And Super Speciality Limited (GKSL) — Board Meeting | 24 August 2026(3 announcements)

· NSE 🟡 Notable Neutral
By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings
1 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board appoints Dr. Disha Bharpoda as additional independent director.
🔄 What Changed
New independent director appointed; shareholder resolution on IPO fund variation approved.
🔮 What's Next
Appointment pending member approval at the next AGM.

The board appointed Dr. Disha Bharpoda as an additional independent director effective August 24, 2026, and noted shareholder approval of a variation in IPO fund usage, while confirming the appointment remains subject to member ratification at the upcoming AGM.

2 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board appoints Dr. Disha Bharpoda as Additional Non-Executive Independent Director
🔄 What Changed
New independent director appointed, pending shareholder approval at AGM
🔮 What's Next
Appointment subject to member approval at next AGM and compliance with regulatory provisions
💡 Investor Takeaway
The appointment strengthens governance but depends on shareholder approval at the upcoming AGM.

Gujarat Kidney and Super Speciality Limited announced the appointment of Dr. Disha Bharpoda as an Additional Non-Executive Independent Director effective 24 August 2026, approved by the Board and subject to shareholder ratification at the upcoming AGM, with her five-year term contingent on regulatory compliance and member approval.

3 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Appointment of Dr. Disha Bharpoda as Additional Non-Executive Independent Director
🔄 What Changed
New independent director appointed; shareholder approval required for IPO fund usage variation
🔮 What's Next
Appointment contingent on AGM approval and regulatory compliance

Gujarat Kidney and Super Speciality Limited announced the appointment of Dr. Disha Bharpoda as an Additional Non-Executive Independent Director effective 24 August 2026, subject to shareholder approval at the upcoming AGM, following a special resolution passed via postal ballot to vary IPO fund usage.

⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →
📊 Stock Analysis — GKSL ✨ Ask AI About This

About Gujarat Kidney And Super Speciality Limited (GKSL)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹1,280.41 Cr P/E: 66.0 ROE: 64.5% ROCE: 77.4%

View full GKSL stock details →

📡 Get AI alerts when GKSL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GKSL — Free

💡 Ask AI about this filing

Ask AI Free →

📊 More GKSL filings

See all GKSL filings →

🔥 Also filed on 24 August 2026

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GKSL files new disclosures

Track GKSL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GKSL — Free

Free account · 2 AI queries/day

⚡ StockFin Pro Go Pro — bigger Radar, no daily limits Upgrade

© 2026 StockFin.ai — AI-powered Indian stock research

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd